Search Results
204 items found for "Transient receptor potential cation channel subfamily M member 4"
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
-31 receptor A , Interleukin-33 receptor , Interleukin-4 receptor alpha , Interleukin-5 receptor alpha Monoclonal antibody , Monocyte chemoattractant protein-4 , MrgprA , MrgprA3 , MrgprCr11 , NGF , NMU , , Transient receptor potential , Transient receptor potential ankyrin 1 , Transient receptor potential cation channel subfamily M member 4 , Transient receptor potential cation channel subfamily M member 8 , Transient receptor potential vanilloid 1 , US Food and Drug Administration , VIP , Vasoactive intestinal
- Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy
Diagnosis and Targeted Therapy Published date October 4, 2024 Abstract "Olfactory receptors (ORs) are This review highlights the specific molecular actions and signaling pathways of olfactory receptors in The potential for precise tumor diagnosis and targeted therapy through therapeutic targeting of olfactory receptors as an adjunct anticancer treatment strategy is being considered." Authors Yi Tang, Ye Tian, Chun-Xia Zhang, Guo-Tai Wang Tags G Protein-coupled receptors , Olfactory receptors
- Plenary Lecture | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
and Hearing and Balance Receptors Abstract Only Available for AGPCR24 Attendees About Jin-Peng Sun " Since starting my laboratory in 2011, I has focused on G protein coupled receptors, in particular, the We have identified the receptor subfamily to sense the steroid hormones. For instance, membrane receptor GPR97 is able to sense glucocorticoid to mediate its rapid actions, the progesterone and 17-hydroxyprogesterone membrane receptor are GPR126.
- From odor to oncology: non-canonical odorant receptors in cancer
Alongside the canonical GPCR odorant receptors, dysregulation of non-canonical odorant receptors such 4A family (MS4As) has been observed in various cancer types, suggesting their contributions to cancer These findings shed light on the potential of non-canonical odorant receptors as therapeutic targets comprehensive overview of the intricate relationships between these chemoreceptors and various types of cancer, potentially Ultimately, this review discusses the potential development of novel therapeutic strategies targeting
- A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages
Immunology A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential In this scenario, metabolite-sensing G-protein coupled receptors (GPCRs), involved in several biological The role of GPR109A was studied in depth and increased expression of this receptor was detected in epithelial Besides, when GPR109A was transiently silenced, the mRNA expression and secretion of IL-1β, IL-6 and A better understanding of metabolite-sensing GPCRs, such as GPR109A, could establish their potential
- Ep 82 with Dr. Lauren M. Slosky
Lauren M. Slosky About Dr. Lauren M. Slosky Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the Slosky’s research is focused on understanding how neuropeptide G protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic benefit. Lauren M.
- Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation
< GPCR News < GPCRs in Oncology and Immunology Leukotriene B4 receptor 2 governs macrophage migration Although leukotriene B4 receptor 2 (BLT2) has been characterized as a low affinity receptor to several results demonstrate that BLT2 mediates macrophage migration during inflammation, which implicates it as a potential Authors Ebru Ermis , Titli Nargis , Kierstin Webster , Sarah A Tersey , Ryan M Anderson , Raghavendra G Mirmira Tags G-protein coupled receptor (GPCR) , Macrophage , inflammation , metabolism , mouse ,
- Regulation and role of mitochondria delta opioid receptors
Committee Sponsors GPCR Retreat Program < Back to schedule Regulation and role of mitochondria delta opioid receptors Date & Time Friday, November 3rd / 10:40 AM Abstract Coming Soon About Louis Gendron "Dr Louis Gendron pharmacology and has published seminal papers where he used various approaches to describe the role of opioid receptors anagesia as well as to study the mechanisms involved in the cellular trafficking of the delta opioid receptor Recently, his group reported the first in vivo GPCR interactome, revealing an important number of new potential
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
< GPCR News < GPCRs in Oncology and Immunology C5aR2 receptor: The genomic twin of the flamboyant C5aR1 C5a is established to interact with a set of genomically related transmembrane receptors, like C5aR1 The C5aR1 is a classical G-protein-coupled receptor (GPCR), whereas C5aR2 is a nonclassical GPCR that tailors immune cell activity potentially through β-arrestins rather than G-proteins. Authors Aurosikha Das, Pulkit K Gupta, Soumendra Rana Tags C5a; C5aR2/C5L2 receptor; lipid bilayer; molecular
- Combinatorial depletions of G-protein coupled receptor kinases in immune cells identify pleiotropic and cell type-specific functions
< GPCR News < GPCRs in Oncology and Immunology Combinatorial depletions of G-protein coupled receptor kinases (GRKs) participate in the regulation of chemokine receptors by mediating receptor desensitization Immune cells commonly express two to four members of the GRK family (GRK2, GRK3, GRK5, GRK6) simultaneously Neutrophils lacking all four GRK family members show increased chemotactic migration responses to a wide Authors Katharina M Glaser, Teresa K Tarrant, Tim Lämmermann Tags B cells; G-protein coupled receptors
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
, making these receptor subtypes better differentiated targets in precision oncology. we performed immunohistochemistry of paired tissue microarrays containing 1125 cores, representing 43 The expression prevalence of both receptors tends to decline with tumor progression. genetic potential during tumor life cycle. We suggest that SST2 and SST3 should be further explored as potential biomarkers and therapeutic tools
- Role and recent progress of P2Y12 receptor in cancer development
< GPCR News < GPCRs in Oncology and Immunology Role and recent progress of P2Y12 receptor in cancer development Published date June 14, 2024 Abstract "P2Y12 receptor (P2Y12R) is an adenosine-activated G protein-coupled receptor (GPCR) that plays a central role in platelet function, hemostasis, and thrombosis. Meanwhile, P2Y12R inhibitors can inhibit this effect, suggesting that P2Y12R may be a potential therapeutic
- Atypical Structure and Function of Typical Chemokine Receptors
Sponsors GPCR Retreat Program < Back to schedule Atypical Structure and Function of Typical Chemokine Receptors Date & Time Saturday, November 4th / 11:00 AM Abstract Coming Soon About Amy Ramsey "One of the principal efforts of our laboratory is to understand the physiological consequences of NMDA receptor deficiency The NMDA receptor is a subtype of glutamate neurotransmitter receptor that regulates the formation and Our laboratory has a long-standing interest in the way that NMDA receptors contribute to the symptoms
- Signaling by Neutrophil G Protein-Coupled Receptors that Regulate the Release of Superoxide Anions
< GPCR News < GPCRs in Oncology and Immunology Signaling by Neutrophil G Protein-Coupled Receptors that Neutrophils, which express many receptors that are members of the large family of G protein-coupled receptors (FPRs) and free fatty acids recognized by free fatty acid receptors (FFARs) regulate neutrophil functions The activation profiles of these receptors include the release of reactive oxygen species (ROS) generated The receptors have signaling and functional similarities, although there are also important differences
- Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors
in Oncology and Immunology Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors Published date December 1, 2022 Abstract G Protein-coupled receptors (GPCRs) are the most frequently Our approach was confirmed by re-discovery of established cancer targets such as the LPA and mGlu receptor families, but also discovered novel GPCRs which had not been linked to cancer before such as the P2Y Receptor Authors Bongers B J , Gorostiola González M , Wang X , van Vlijmen HWT , Jespers W , Gutiérrez-de-Terán
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
adapt this technology for high-throughput screening of pharmacological compound libraries to identify potential There, I investigated Two-Pore-Potassium channels using electrophysiology, molecular and chemical biology Mancini (2), Samya Aouad (2,3), Herthana Kandasamy (2), Sandra Morrissette (2), Arhamatoulaye Maiga (4) , Michel Bouvier (4), Richard Leduc (1), Laurent Sabbagh (2) 1. Université Claude Bernard - Lyon, Faculté de Pharmacie, Lyon, France 4.
- Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis
< GPCR News < GPCRs in Oncology and Immunology Identification of a G-protein coupled receptor-related G protein-coupled receptors (GPCRs, the largest family of human cell surface receptors) are associated The predictive ability of the model was evaluated by Kaplan-Meier (K-M) survival analysis. K-M analysis of the prognostic model showed that it could differentiate high- and low-risk patients, Shaohan Ma, Ruyue Li, Guangqi Li, Meng Wei, Bowei Li, Yongmei Li, Chunfang Ha Tags G protein-coupled receptor
- Ep 126 with Dr. Françoise Bachelerie
The team’s projects are devoted to the activation/function of CXCR4-ACKR3 (CXCR7) receptors of the CXCL12 which are commensal inhabiting the healthy human epithelium (virome) while presenting an oncogenic potential FB’ team has identified the orphan CXCR7/ACKR3 receptor as being the 2nd receptor for CXCL12, which behaves FB is a member of various international committees in the field, including the one that reviewed the receptors (including the CXCR7/ACKR3). " Dr.
- The EBI2 receptor is coexpressed with CCR5 in CD4+ T cells and boosts HIV-1 R5 replication
< GPCR News < GPCRs in Oncology and Immunology The EBI2 receptor is coexpressed with CCR5 in CD4+ T cells boosts HIV-1 R5 replication Published date May 21, 2024 Abstract " Objective: CCR5, a G protein-coupled receptor (GPCR), is used by most HIV strains as a coreceptor. vpr, early and late HIV-1 transcriptions by qPCR, NFkB nuclear activation by immunofluorescence and transfection
- G protein-coupled receptor-mediated signaling of immunomodulation in tumor progression
< GPCR News < GPCRs in Oncology and Immunology G protein-coupled receptor-mediated signaling of immunomodulation in tumor progression Published date July 31, 2024 Abstract "G protein-coupled receptors (GPCRs) are Therefore, GPCRs are potential targets for cancer immunotherapy.
- Ep 113 with Dr. Prasenjit Saha
Specifically, I am interested in understanding dysregulated G-protein coupled receptor (GPCR) signaling This study demonstrated that PAG is a potential diagnostic marker for CVD as it causes serious fatal In this study, I discovered adrenergic receptors (α2A, α2B, and β2-adrenergic receptors) that serve as the gut microbial metabolite (PAG) receptor and characterized the receptor-metabolite interaction. However, the pursuit of allosteric modulators has gained attention as they have the potential to fine-tune
- Ep 152 with Dr Arthur Christopoulos
They explored the evolution of the field, allosteric modulation concepts, and potential therapeutic approaches families, and the potential of hybrid molecules. They also delved into the different signaling of Class B receptors and the potential for modulation at The discussion underscored the potential of allosteric modulators as drugs, despite challenges in the They also discussed the potential of certain drugs, like flumazenil, as 'nails' or compounds that could
- Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5
Oncology and Immunology Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors group of CC-chemokines are the macrophage inflammatory proteins (MIP), which are promiscuous for the receptors These 3 to 10-residue peptides displayed weak potency but, surprisingly, retained their signaling on Walser , Stavroula Louka , Ida Aaberg Lillethorup , Jon Våbenø , Katrine Qvortrup , Paul Proost , Mette M
- Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers
< GPCR News < GPCRs in Oncology and Immunology Expanding role of CXCR2 and therapeutic potential of CXCR2 in inflammatory diseases and cancers Published date March 15, 2023 Abstract " C-X-C motif chemokine receptor 2 (CXCR2) is G protein-coupled receptor (GPCR) and plays important roles in various inflammatory diseases
- Ep 71 with Dr. Jean Martin Beaulieu
for Beta-arrestin signaling in the brain in vivo and has established its importance in D2 dopamine receptors These receptors belong to the super-family of G-protein coupled receptors (GPCR), the major molecular (e.g. lithium) used for bipolar disorder therapy target signaling mechanisms regulated by dopamine receptors how cell surface express proteins can act as allosteric modulators of D2R signaling and explores the potential identification of an RNA binding protein (FXR1P) involved in the regulation of protein synthesis as a potential
- Ep 02 with Dr. Terry Hébert
interested in membrane protein as he followed the biology of a bacterial toxin that affects a mammalian ion channel Today he and his team are working on understanding receptor signaling in specialized cellular environments to gain a better grasp of receptor function in pathophysiological settings with a special interest in His favorite GPCR is the angiotensin 1 receptor, especially for its ability to activate a large variety
- Interplay between G protein-coupled receptors and nanotechnology
< GPCR News < GPCRs in Oncology and Immunology Interplay between G protein-coupled receptors and nanotechnology Published date July 28, 2023 Abstract "G protein-coupled receptors (GPCRs), as the largest family of membrane receptors, actively modulate plasma membrane and endosomal signalling. , GPCR ligands can endow nanoparticles with active targeting capacity for specific cells via ligand-receptor binding and mediate receptor-dependent endocytosis of nanoparticles.
- Dopamine-Mediated Motor Recovery after Ischemic Stroke
Marc Caron, where I cloned the dopamine D5 receptor gene and investigated the regulation of dopaminergic and adrenergic receptors. currently developing the translational component of our research to capitalize on the druggability potential More specifically, we investigate the druggability potential of new signaling partners we identified that drive the formation of different DA receptor complexes.